1. Home
  2. FNB vs GRFS Comparison

FNB vs GRFS Comparison

Compare FNB & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo F.N.B. Corporation

FNB

F.N.B. Corporation

HOLD

Current Price

$17.77

Market Cap

6.3B

Sector

Finance

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.07

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNB
GRFS
Founded
1864
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.5B
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
FNB
GRFS
Price
$17.77
$8.07
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$19.70
$10.15
AVG Volume (30 Days)
7.5M
588.1K
Earning Date
04-16-2026
07-28-2022
Dividend Yield
2.97%
1.76%
EPS Growth
22.83
N/A
EPS
1.56
N/A
Revenue
N/A
N/A
Revenue This Year
$14.12
$4.49
Revenue Next Year
$8.35
$6.42
P/E Ratio
$11.20
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$12.88
$6.90
52 Week High
$19.14
$11.14

Technical Indicators

Market Signals
Indicator
FNB
GRFS
Relative Strength Index (RSI) 57.01 45.65
Support Level $17.38 $7.52
Resistance Level $18.09 $8.88
Average True Range (ATR) 0.40 0.19
MACD 0.00 -0.02
Stochastic Oscillator 45.83 21.97

Price Performance

Historical Comparison
FNB
GRFS

About FNB F.N.B. Corporation

F N B Corp provides a full range of financial services, principally to consumers, corporations, governments, and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management, and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: